Barry Labinger Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Barry Labinger.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Barry Labinger. Barry Labinger is Exec VP & CCO in HUMAN GENOME SCIENCES INC ($HGSI) and Exec VP, CCO & CFO in HUMAN GENOME SCIENCES INC ($HGSI) and EVP, Biosciences Div. in Emergent BioSolutions Inc. ($EBS) and President and CEO in Checkmate Pharmaceuticals, Inc. ($CMPI).
Latest Insider Trading Transactions of Barry Labinger
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CMPI, EBS, HGSI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 10 2020 | CMPI | Checkmate Pharmace ... | Labinger Barry | President and CEO | Option Exercise | A | 15.00 | 445,819 | 6,687,285 | 445,819 | |
Nov 17 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 36.50 | 3,376 | 123,224 | 25,182 | 28.6 K to 25.2 K (-11.82 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 20.94 | 10,094 | 211,368 | 0 | |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 20.94 | 10,095 | 211,389 | 0 | |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 28.09 | 9,373 | 263,288 | 0 | |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Payment of Exercise | F | 35.88 | 1,671 | 59,955 | 28,558 | 30.2 K to 28.6 K (-5.53 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 36.00 | 10,094 | 363,384 | 30,229 | 40.3 K to 30.2 K (-25.03 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Buy | M | 20.94 | 10,094 | 211,368 | 40,323 | 30.2 K to 40.3 K (+33.39 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 35.50 | 10,095 | 358,373 | 30,229 | 40.3 K to 30.2 K (-25.03 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Buy | M | 20.94 | 10,095 | 211,389 | 40,324 | 30.2 K to 40.3 K (+33.40 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 35.50 | 9,373 | 332,742 | 30,229 | 39.6 K to 30.2 K (-23.67 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Buy | M | 28.09 | 9,373 | 263,288 | 39,602 | 30.2 K to 39.6 K (+31.01 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 35.51 | 6,564 | 233,088 | 30,229 | 36.8 K to 30.2 K (-17.84 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | A | 28.99 | 21,517 | 623,778 | 21,517 | |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Payment of Exercise | F | 29.00 | 1,594 | 46,226 | 36,793 | 38.4 K to 36.8 K (-4.15 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Grant | A | 0.00 | 10,762 | 0 | 38,387 | 27.6 K to 38.4 K (+38.96 %) |
Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | D | 13.43 | 300,000 | 4,029,000 | 0 | |
Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | D | 10.11 | 55,194 | 558,011 | 0 | |
Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | D | 10.89 | 37,500 | 408,375 | 0 | |
Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | D | 8.23 | 108,000 | 888,840 | 0 | |
Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | D | 0.52 | 53,140 | 27,633 | 0 | |
Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | D | 4.92 | 39,015 | 191,954 | 0 | |
Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | D | 10.62 | 117,000 | 1,242,540 | 0 | |
Aug 01 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Sell | U | 14.25 | 49,842 | 710,249 | 0 | 49.8 K to 0 (-100.00 %) |
Jul 26 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 0.52 | 21,880 | 11,378 | 53,140 | |
Jul 26 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 4.92 | 9,600 | 47,232 | 39,015 | |
Jul 26 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 4.92 | 9,600 | 47,232 | 49,842 | 40.2 K to 49.8 K (+23.86 %) |
Jul 26 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 0.52 | 21,880 | 11,378 | 40,242 | 18.4 K to 40.2 K (+119.16 %) |
Mar 12 2012 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | A | 8.23 | 108,000 | 888,840 | 108,000 | |
Jul 27 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 10.11 | 7,306 | 73,864 | 55,194 | |
Jul 27 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 4.92 | 3,056 | 15,036 | 48,615 | |
Jul 27 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 10.62 | 8,000 | 84,960 | 117,000 | |
Jul 27 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 4.92 | 3,056 | 15,036 | 18,362 | 15.3 K to 18.4 K (+19.97 %) |
Jul 27 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 10.11 | 7,306 | 73,864 | 15,306 | 8 K to 15.3 K (+91.33 %) |
Jul 27 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 10.62 | 8,000 | 84,960 | 8,000 | 0 to 8 K |
May 04 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 4.92 | 7,347 | 36,147 | 51,671 | |
May 04 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Sell | S | 30.00 | 7,347 | 220,410 | 0 | 7.3 K to 0 (-100.00 %) |
May 04 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 4.92 | 7,347 | 36,147 | 7,347 | 0 to 7.3 K |
Apr 29 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 0.52 | 28,113 | 14,619 | 75,020 | |
Apr 29 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 4.92 | 11,853 | 58,317 | 59,018 | |
Apr 29 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Sell | S | 30.00 | 28,113 | 843,390 | 0 | 28.1 K to 0 (-100.00 %) |
Apr 29 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Sell | S | 30.00 | 11,853 | 355,590 | 28,113 | 40 K to 28.1 K (-29.66 %) |
Apr 29 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 4.92 | 11,853 | 58,317 | 39,966 | 28.1 K to 40 K (+42.16 %) |
Apr 29 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 0.52 | 28,113 | 14,619 | 28,113 | 0 to 28.1 K |
Mar 21 2011 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | A | 27.10 | 120,000 | 3,252,000 | 120,000 | |
Sep 02 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 4.92 | 50,000 | 246,000 | 70,871 | |
Sep 02 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Sell | S | 30.02 | 50,000 | 1,500,780 | 0 | 50 K to 0 (-100.00 %) |
Sep 02 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 4.92 | 50,000 | 246,000 | 50,000 | 0 to 50 K |
Aug 30 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 4.92 | 16,079 | 79,109 | 120,871 | |
Aug 30 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 4.92 | 13,050 | 64,206 | 136,950 | |
Aug 30 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Sell | S | 28.50 | 16,079 | 458,287 | 0 | 16.1 K to 0 (-100.00 %) |
Aug 30 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 4.92 | 16,079 | 79,109 | 16,079 | 0 to 16.1 K |
Aug 30 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Sell | S | 28.53 | 13,050 | 372,361 | 0 | 13.1 K to 0 (-100.00 %) |
Aug 30 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 4.92 | 13,050 | 64,206 | 13,050 | 0 to 13.1 K |
Jul 27 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 0.52 | 21,871 | 11,373 | 103,133 | |
Jul 27 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Sell | S | 27.05 | 21,871 | 591,525 | 0 | 21.9 K to 0 (-100.00 %) |
Jul 27 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 0.52 | 21,871 | 11,373 | 21,871 | 0 to 21.9 K |
Mar 11 2010 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | A | 32.56 | 135,000 | 4,395,600 | 135,000 | |
Dec 01 2009 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | M | 0.52 | 24,996 | 12,998 | 125,004 | |
Dec 01 2009 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Sell | S | 27.37 | 44,700 | 1,223,439 | 0 | 44.7 K to 0 (-100.00 %) |
Dec 01 2009 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Sell | S | 27.37 | 24,996 | 684,141 | 44,700 | 69.7 K to 44.7 K (-35.86 %) |
Dec 01 2009 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Buy | M | 0.52 | 24,996 | 12,998 | 69,696 | 44.7 K to 69.7 K (+55.92 %) |
Mar 12 2009 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | A | 0.52 | 150,000 | 78,000 | 150,000 | |
Mar 11 2008 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | A | 4.92 | 150,000 | 738,000 | 150,000 | |
Mar 13 2007 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | A | 10.62 | 125,000 | 1,327,500 | 125,000 | |
Aug 18 2006 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Sell | S | 9.79 | 5,300 | 51,887 | 44,700 | 50 K to 44.7 K (-10.60 %) |
Jul 12 2006 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP & CCO | Option Exercise | A | 10.11 | 62,500 | 631,875 | 62,500 | |
Mar 16 2006 | HGSI | HUMAN GENOME SCIEN ... | Labinger Barry | Exec VP, CCO & CFO | Option Exercise | A | 10.89 | 37,500 | 408,375 | 37,500 |
Page: 1